Drug intelligence / Profile preview

Remax Q10

Development stage: Unknown
Lead developer: Renomed Lifesciences
Modality: Small Molecules
Administration: Oral

Overview

Remax Q10 is a multi-ingredient nutraceutical supplement developed and marketed by Renomed Lifesciences. Formulated as an oral softgel capsule, it contains a combination of Coenzyme Q10, Lycopene, Omega-3 fatty acids, L-Arginine, and Selenium. The product is designed to support the immune system and provide antioxidant benefits by leveraging the synergistic effects of its components. It is primarily available in India as an over-the-counter wellness product.

Brand names: Remax Q10

Beyond the preview

Go deeper on Remax Q10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remax Q10.

Explore the full profile